Search results
Results From The WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
In the same year Switzerland was the second largest exporter of packaged medicine in the world, with about 11% of the global total, worth $36.5 billion. [3] Switzerland is home to many pharmaceutical companies, including very large groups, such as Novartis and Hoffmann-La Roche. In 2013, 41 life science companies had their international ...
Baar-based commodities trading and mining giant and the world's third-largest family business. [5] 64 Nestlé: $90,814 328,000 Transnational consumer goods conglomerate and the largest food and beverage company in the world. The firm has more than 8,000 brands, including Gerber, Carnation, and Lean Cuisine. 112 Zurich Insurance Group: $67,245 ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
For more companies, head on over to 5 Biggest European Pharmaceutical Companies. Alongside the United States, Europe has some of the most advanced industries and economies in the world.
Fifteen Swiss companies are included on Fortune's "Global 500" list (in 2011). As of 2018 the largest non-financial companies in terms of annual revenue were Glencore, Vitol and Trafigura, with Nestlé as the largest employer. The largest banks were UBS and Credit Suisse, and the largest insurance company was Zurich Insurance Group.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Take a look around the pharmaceutical industry and you won't find many companies with market caps exceeding $100 billion (seven by my count). If you discount non-pharmaceutical businesses at Roche ...